1. Home
  2. WHG vs RCEL Comparison

WHG vs RCEL Comparison

Compare WHG & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WHG
  • RCEL
  • Stock Information
  • Founded
  • WHG 1983
  • RCEL N/A
  • Country
  • WHG United States
  • RCEL United States
  • Employees
  • WHG N/A
  • RCEL N/A
  • Industry
  • WHG Investment Managers
  • RCEL Medical/Dental Instruments
  • Sector
  • WHG Finance
  • RCEL Health Care
  • Exchange
  • WHG Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • WHG 146.3M
  • RCEL 170.8M
  • IPO Year
  • WHG 2002
  • RCEL N/A
  • Fundamental
  • Price
  • WHG $14.56
  • RCEL $6.04
  • Analyst Decision
  • WHG
  • RCEL Strong Buy
  • Analyst Count
  • WHG 0
  • RCEL 4
  • Target Price
  • WHG N/A
  • RCEL $17.25
  • AVG Volume (30 Days)
  • WHG 16.5K
  • RCEL 339.6K
  • Earning Date
  • WHG 04-30-2025
  • RCEL 05-08-2025
  • Dividend Yield
  • WHG 4.06%
  • RCEL N/A
  • EPS Growth
  • WHG N/A
  • RCEL N/A
  • EPS
  • WHG 0.04
  • RCEL N/A
  • Revenue
  • WHG $95,241,000.00
  • RCEL $71,661,000.00
  • Revenue This Year
  • WHG N/A
  • RCEL $59.50
  • Revenue Next Year
  • WHG N/A
  • RCEL $28.89
  • P/E Ratio
  • WHG $309.53
  • RCEL N/A
  • Revenue Growth
  • WHG 6.08
  • RCEL 41.35
  • 52 Week Low
  • WHG $11.11
  • RCEL $5.46
  • 52 Week High
  • WHG $18.03
  • RCEL $14.16
  • Technical
  • Relative Strength Index (RSI)
  • WHG 38.75
  • RCEL 33.65
  • Support Level
  • WHG $14.78
  • RCEL $5.46
  • Resistance Level
  • WHG $15.46
  • RCEL $6.38
  • Average True Range (ATR)
  • WHG 0.43
  • RCEL 0.46
  • MACD
  • WHG -0.02
  • RCEL -0.07
  • Stochastic Oscillator
  • WHG 4.72
  • RCEL 29.44

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: